ACUVUE^® OASYS with HYDRACLEAR^® PLUS Technology

FOOTNOTES

^±Transitions, the Transitions logo, and Transitions Light Intelligent Technology are trademarks of
Transitions Optical, Inc. used under license by Transitions Optical Limited and Johnson & Johnson Vision Care, Inc.
^¥22 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as primary or secondary endpoint for ACUVUE^® OASYS Brand 2-week family contact lenses vs. competitors’ products as of April 30, 2023.
^‡www.clinicaltrials.gov is a website maintained by the NIH. Since February 2007, 28 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE^® OASYS Brand families of contact lenses vs. competitors’ products. Review conducted as of April 30, 2023.
^*Source Euromonitor International Limited; Eyewear 2024 edition; value sales at rsp, all retail channels, 2022 data; “ACUVUE^® family of brands” represents aggregated sales of the following brands: 1-DAY ACUVUE^®, ACUVUE^® OASYS, ACUVUE^® ADVANCE, ACUVUE^®, and ACUVUE^® 2.
⁺Source Euromonitor International Limited; Eyewear 2023 edition; value sales at rsp, all retail channels, 2021 data; “ACUVUE^® family of brands” represents aggregated sales of the following brands: 1-DAY ACUVUE^®, ACUVUE^® OASYS, ACUVUE^® ADVANCE, ACUVUE^®, and ACUVUE^® 2.
^#Helps protect against transmission of harmful UV radiation to the cornea & into the eye.
^{^}WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed.
NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV- blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care professional for more information.
^†Includes Air Optix Aqua, Avaira, Biofinity, and Ultra.
^**Individual baseline responses were collected from 1 to 44 clinical trials of current spherical, daily wear reusable SiHy wearers in the United States ages 18-45 over a 3-year period. The number of analyzed subjects for each response ranged from 212 to 3,495.
^‡Includes Air Optix Aqua, Avaira, Biofinity, and Ultra

REFERENCES

1. JJV Data on File 2018. Material Properties: ACUVUE^® OASYS Brand Contact Lenses with HYDRACLEAR^® PLUS, ACUVUE^® OASYS with Transitions^TM Light Intelligent Technology^TM, and other reusable contact lenses.
2. JJV Data on File 2017. Subjective Responses of ACUVUE^® OASYS Brand Contact Lenses and Habitual Contact Lenses during Digital Device Usage
3. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
4. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE^® OASYS vs. ULTRA, n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period.
5. JJV Data on File 2018. ACUVUE^® Brand UV Claims.
6. Fadli Z, Mahadevan S, Scales C. Antioxidant Capacity of a Phenolic Benzotriazole (Norbloc) in Soft
Contact Lens Materials: A Benefit Beyond UV Blocking. Invest. Ophthalmol. Vis. Sci. 2018;59:1759.
7. JJV Data on File 2022: Master Brand Claims on Clinical Performance and Overall Material Properties for ACUVUE^® Brand Soft Contact Lenses

PP2023MLT6356